KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Regeneron Pharmaceuticals (REGN) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Regeneron Pharmaceuticals (REGN) over the last 14 years, with Q1 2022 value amounting to $127.6 million.

  • Regeneron Pharmaceuticals' Shares Outstanding rose 467.6% to $127.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $127.6 million, marking a year-over-year increase of 467.6%. This contributed to the annual value of $126.2 million for FY2021, which is 386.83% up from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Shares Outstanding of $127.6 million as of Q1 2022, which was up 467.6% from $126.2 million recorded in Q4 2021.
  • In the past 5 years, Regeneron Pharmaceuticals' Shares Outstanding registered a high of $127.6 million during Q1 2022, and its lowest value of $109.7 million during Q1 2018.
  • Moreover, its 5-year median value for Shares Outstanding was $116.0 million (2020), whereas its average is $117.1 million.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Shares Outstanding skyrocketed by 146.12% in 2018 and then skyrocketed by 749.33% in 2020.
  • Regeneron Pharmaceuticals' Shares Outstanding (Quarter) stood at $111.1 million in 2018, then grew by 1.98% to $113.3 million in 2019, then grew by 7.24% to $121.5 million in 2020, then increased by 3.87% to $126.2 million in 2021, then grew by 1.11% to $127.6 million in 2022.
  • Its last three reported values are $127.6 million in Q1 2022, $126.2 million for Q4 2021, and $124.6 million during Q3 2021.